Triple-negative breast cancer (TNBC), one subtype of breast cancer, lacks progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2) (Yin et al., 2020). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.